Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 46 results.
User Information
Export Records
  1. 1.   N-Substituted Bicyclic Carbamoyl Pyridones: Integrase Strand Transfer Inhibitors that Potently Inhibit Drug-Resistant HIV-1 Integrase Mutants
  2. Mahajan,Pankaj; Smith,Steven; Li, Min; Craigie, Robert; Hughes,Stephen; Zhao,Xuezhi; Burke,Terrence
  3. ACS Infectious Diseases. 2024, Feb 12;
  1. 2.   A Practical Approach to Bicyclic Carbamoyl Pyridones with Application to the Synthesis of HIV-1 Integrase Strand Transfer Inhibitors
  2. Mahajan,Pankaj; Smith,Steven; Hughes,Stephen; Zhao,Xue Zhi; Burke,Terrence
  3. Molecules (Basel, Switzerland). 2023, Feb 02; 28(3):
  1. 3.   Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs
  2. Smith, Steven J.; Zhao,Xue Zhi; Passos, Dario Oliveira; Lyumkis, Dmitry; Burke,Terrence; Hughes,Stephen
  3. Viruses (Basel). 2021, Jan 29; 13(2):
  1. 4.   Clinical Trial Assessment of Infrastructure Matrix Tool to Improve the Quality of Research Conduct in the Community
  2. Dimond, E. P.; Zon, R. T.; Weiner, B. J.; St Germain, D.; Denicoff, A. M.; Dempsey, K.; Carrigan, A. C.; Teal, R. W.; Good, M. J.; McCaskill-Stevens, W.; Grubbs, S. S.; Dimond, E. P.; Zon, R. T.; Weiner, B. J.; St Germain, D.; Denicoff, A. M.; Dempsey, K.; Carrigan, A. C.; Teal, R. W.; Good, M. J.; McCaskill-Stevens, W.; Grubbs, S. S.
  3. Journal of Oncology Practice. 2016, Jan; 12(1): 63-4, e23-35.
  1. 5.   Evaluation of a library outreach program to research labs
  2. Brandenburg, M. D.; Doss, A.; Frederick, T. E.
  3. Medical reference services quarterly. 2010, Jul; 29(3): 249-59.
  1. 6.   Connecting chemosensitivity, gene expression and disease
  2. Covell, D. G.
  3. Trends in Pharmacological Sciences. 2008 29(1): 1-5.
  1. 7.   The NCI60 human tumour cell line anticancer drug screen
  2. Shoemaker, R. H.
  3. Nature Reviews Cancer. 2006, Oct; 6(10): 813-823.
  1. 8.   Mining the NCI antiviral compounds for HIV-1 integrase inhibitors
  2. Deng, J. X.; Kelley, J. A.; Barchi, J. J.; Sanchez, T.; Dayam, R.; Pommier, Y.; Neamati, N.
  3. Bioorganic & Medicinal Chemistry. 2006, JUN 1; 14(11): 3785-3792.
  1. 9.   Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen
  2. Huang, R.; Wallqvist, A.; Covell, D. G.
  3. Genomics. 2006, MAR; 87(3): 315-328.
  1. 10.   Evaluating chemical structure similarity as an indicator of cellular growth inhibition
  2. Wallqvist, A.; Huang, R. L.; Thanki, N.; Covell, D. G.
  3. Journal of Chemical Information and Modeling. 2006, JAN-FEB; 46(1): 430-437.
  1. 11.   Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action
  2. Huan, R.; Wallqvist, A.; Thanki, N.; Covell, D.
  3. Clinical Cancer Research. 2005, DEC 15; 11(24, Part 2 Suppl. S): 9069S-9069S.
  1. 12.   Antitumor activity and distribution of pyrroloiminoquinones in the sponge genus Zyzzya
  2. Dijoux, M. G.; Schnabel, P. C.; Hallock, Y. F.; Boswell, J. L.; Johnson, T. R.; Wilson, J. A.; Irel, C. M.; van Soest, R.; Boyd, M. R.; Barrows, L. R.; Cardellina, J. H.
  3. Bioorganic & Medicinal Chemistry. 2005, NOV 1; 13(21): 6035-6044.
  1. 13.   Drugs aimed at targeting characteristic karyotypic phenotypes of cancer cells
  2. Wallqvist, A.; Huang, R.; Covell, D. G.; Roschke, A. V.; Gelhaus, K. S.; Kirsch, I. R.
  3. Molecular Cancer Therapeutics. 2005, OCT; 4(10): 1559-1568.
  1. 14.   Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
  2. Kong, D. H.; Park, E. J.; Stephen, A. G.; Calvani, M.; Cardellina, J. H.; Monks, A.; Fisher, R. J.; Shoemaker, R. H.; Melillo, G.
  3. Cancer Research. 2005, OCT 1; 65(19): 9047-9055.
  1. 15.   Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: A clinical and molecular genetic investigation
  2. Matyakhina, L.; Freedman, R. J.; Bourdeau, I.; Wei, M. H.; Stergiopoulos, S. G.; Chidakel, A.; Walther, M.; bu-Asab, M.; Tsokos, M.; Keil, M.; Toro, J.; Linehan, W. M.; Stratakis, C. A.
  3. Journal of Clinical Endocrinology & Metabolism. 2005, JUN; 90(6): 3773-3779.
  1. 16.   A high-throughput fluorescence-anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factors
  2. Rishi, V.; Potter, T.; Laudeman, J.; Reinhart, R.; Silvers, T.; Selby, M.; Stevenson, T.; Krosky, P.; Stephen, A. G.; Acharya, A.; Moll, J.; Oh, W. J.; Scudiero, D.; Shoemaker, R. H.; Vinson, C.
  3. Analytical Biochemistry. 2005, MAY 15; 340(2): 259-271.
  1. 17.   Elucidation of thioredoxin as a molecular target for antitumor quinols
  2. Bradshaw, T. D.; Matthews, C. S.; Cookson, J.; Chew, E. H.; Shah, M.; Bailey, K.; Monks, A.; Harris, E.; Westwell, A. D.; Wells, G.; Laughton, C. A.; Stevens, M. F. G.
  3. Cancer Research. 2005, MAY 1; 65(9): 3911-3919.
  1. 18.   Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations
  2. Johnston, E.; Dupnik, K. M.; Gonzales, M. J.; Winters, M. A.; Rhee, S. Y.; Imamichi, T.; Shafer, R. W.
  3. Aids. 2005, APR 29; 19(7): 731-733.
  1. 19.   Synthesis of nonracemic 3-deoxyschweinfurthin B
  2. Neighbors, J. D.; Beutler, J. A.; Wiemer, D. F.
  3. Journal of Organic Chemistry. 2005, FEB 4; 70(3): 925-931.
  1. 20.   Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones
  2. Budihas, S. R.; Gorshkova, I.; Gaidamakov, S.; Wamiru, A.; Bona, M. K.; Parniak, M. A.; Crouch, R. J.; McMahon, J. B.; Beutler, J. A.; Le Grice, S. F. J.
  3. Nucleic Acids Research. 2005 33(4): 1249-1256.
  1. 21.   Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action
  2. Huang, R.; Wallqvist, A.; Thanki, N.; Covell, D. G.
  3. Pharmacogenomics Journal. 2005 5(6): 381-399.
  1. 22.   Anticancer metal compounds in NCI's tumor-screening database: putative mode of action
  2. Huang, R. L.; Wallqvist, A.; Covell, D. G.
  3. Biochemical Pharmacology. 2005 69(7): 1009-1039.
  1. 23.   Components of the cell death machine and drug sensitivity of the National Cancer Institute cell line panel
  2. Svingen, P. A.; Loegering, D.; Rodriquez, J.; Meng, X. W.; Mesner, P. W.; Holbeck, S.; Monks, A.; Krajewski, S.; Scudiero, D. A.; Sausville, E. A.; Reed, J. C.; Lazebnik, Y. A.; Kaufmann, S. H.
  3. Clinical Cancer Research. 2004, OCT 15; 10(20): 6807-6820.
  1. 24.   Structure-based discovery of nonpeptidic small organic compounds to block the T cell response to myelin basic protein
  2. Koehler, N. K. U.; Yang, C. Y.; Varady, J.; Lu, Y. P.; Wu, X. W.; Liu, M.; Yin, D. X.; Bartels, M.; Xu, B. Y.; Roller, P. P.; Long, Y. Q.; Li, P.; Kattah, M.; Cohn, M. L.; Moran, K.; Tilley, E.; Richert, J. R.; Wang, S. M.
  3. Journal of Medicinal Chemistry. 2004, OCT 7; 47(21): 4989-4997.
  1. 25.   Classification of proliferative pulmonary lesions of the mouse: Recommendations of the mouse models of human cancers consortium
  2. Nikitin, A. Y.; Alcaraz, A.; Anver, M. R.; Bonson, R. T.; Cardiff, R. D.; Dixon, D.; Fraire, A. E.; Gabrielson, E. W.; Gunning, W. T.; Haines, D. C.; Kaufman, M. H.; Linnoila, R. I.; Maronpot, R. R.; Rabson, A. S.; Reddick, R. L.; Rehm, S.; Rozengurt, N.; Schuller, H. M.; Shmidt, E. N.; Travis, W. D.; Ward, J. M.; Jacks, T.
  3. Cancer Research. 2004 64(7): 2307-2316.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel